Monschein, T; Dekany, S; Zrzavy, T; Ponleitner, M; Altmann, P; Bsteh, G; Kornek, B; Rommer, P; Enzinger, C; Di, Pauli, F; Kraus, J; Berger, T; Leutmezer, F; Guger, M, , Austrian, MS, Treatment, Registry, (AMSTR).
Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).
J Neurol. 2023; 270(8):3787
Doi: 10.1007/s00415-023-11784-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG